Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters. - Wikidata - awgldk - TriplyDB

Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

http://www.wikidata.org/entity/Q33573499

about

Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review Analysis of process parameters affecting spray-dried oily core nanocapsules using factorial design.Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion.Engineering nanomedicines for improved melanoma therapy: progress and promises.Self-assembled liquid crystalline nanoparticles as an ophthalmic drug delivery system. Part I: influence of process parameters on their preparation studied by experimental design.Cubic liquid crystalline nanoparticles: optimization and evaluation for ocular delivery of tropicamide.

P2860

Q28394719-8934D262-F3F4-4CCA-9664-A23547BEFB2C Q33691795-1AEC5B4C-34C4-4327-B94D-55BC97BD1763 Q34280372-D8E84E6A-61DF-466E-9831-11C9831CB84E Q34784522-D5A9677D-9336-444E-AA8C-5DA4B07116F4 Q36032477-FF2EB2B7-6B9C-422E-869B-C2384211018F Q36936646-F245DCA1-9300-4A05-9EA3-BA4A23D30BDC Q44774296-93A631A5-8B7A-4677-AC19-099F3C27E4CB Q53174701-80757E2B-410F-4360-BA1C-680B398FD272

P2860

Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

http://www.wikidata.org/entity/Q33573499

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

@ast

Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

@en

Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

@nl

type

label

Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

@ast

Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

@en

Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

@nl

prefLabel

Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

@ast

Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

@en

Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

@nl

P1433

Q33573499-C8ECBB2A-7B95-47B6-89CE-FB94655E5A2B

P1476

Q33573499-5B53F279-278D-4AE6-8113-B65DF0203CA4

P2093

Q33573499-506562C9-F2C2-4277-AE3B-75FA8B3EEC7E

Q33573499-EFA0D476-7F46-4AEA-B4B2-327EE86C5099

P2860

Q33573499-1882AD85-83A5-414A-B75E-951BB47A6A1E

Q33573499-2717563E-FEBA-4F64-B9C0-8F4412D4983E

Q33573499-40C739BC-2B46-486C-8654-19F89D099E74

Q33573499-4EA833D8-B8A6-4C7B-8093-22268D3BEB7E

Q33573499-78778DD0-2EF8-46DC-BE5D-E537535902BF

Q33573499-82F01E90-4A59-4C71-B93A-C427B408E26B

Q33573499-88944DF5-8F88-4F78-B4AD-DA8376786084

Q33573499-8EB89206-D917-43B9-96F7-749DFAD52130

Q33573499-96C92B24-CC32-406A-B488-F06FBD38627A

Q33573499-981CAD21-3C91-4D78-8F12-81BDF534D90A

P2888

Q33573499-D3284E9C-64E4-40B1-9C40-50566A1C84F3

P304

Q33573499-18165E0C-B440-429B-8145-2AC39F35D275

P31

Q33573499-C1A4EECC-5FAB-4287-95E0-AD6AA26DEBBA

P356

Q33573499-92539F80-E908-4AB0-BCC2-5F1215A143AD

P407

Q33573499-02C5B10A-F7E6-4D59-835A-48EAB22C58AE

P433

Q33573499-8F0A526A-FD13-4234-A068-CAE9FC302F31

P478

Q33573499-83AE884C-C6A1-4A82-A737-CC31B13D6A84

P50

Q33573499-D645B873-FCE0-4FA7-BDFD-723159ED3FCF

P577

Q33573499-68F793C7-6BB0-4DD0-A34A-9ED9376796DA

P5875

Q33573499-D534481B-87C0-435A-B060-444582E853C9

P6179

Q33573499-2C944259-827E-40BB-88F7-E65EC754D647

P698

Q33573499-CC596702-43FC-4F47-9F06-0D2375EA7C6D

P932

Q33573499-410CF092-B980-4E04-B6A0-DB71BC56BD67

P356

S12249-009-9296-0

P1433

AAPS PharmSciTech

P1476

Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

@en

P2093

Bi-Botti C Youan

http://www.w3.org/2001/XMLSchema#string

Di Bei

http://www.w3.org/2001/XMLSchema#string

P2860

Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

Cubic phase gels as drug delivery systems.

Long-circulating and target-specific nanoparticles: theory to practice.

Cubic phase nanoparticles (Cubosome): principles for controlling size, structure, and stability.

Cubosomes: an overview.

5-Fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release study

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.

Enhanced loading of water-soluble actives into bicontinuous cubic phase liquid crystals using cationic surfactants.

Nanostructure of the stratum corneum extracellular lipid matrix as observed by cryo-electron microscopy of vitreous skin sections.

Preparation and application of carboxymethyl yam (Dioscorea esculenta) starch.

P2888

s12249-009-9296-0

P304

1040-1047

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12249-009-9296-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Jacob Marszalek

P577

2009-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26749448

http://www.w3.org/2001/XMLSchema#string

P6179

1030301102

http://www.w3.org/2001/XMLSchema#string

P698

19688599

http://www.w3.org/2001/XMLSchema#string

P932

2802167

http://www.w3.org/2001/XMLSchema#string